We hypothesize that PCSK9, which we found to be increased in the CSF of AD patients [6], by degrading the neuronal apoE-recognizing receptors and possibly affecting other steps of the brain cholesterol transport, may reduce cholesterol supply to neurons, with potentially deleterious consequences for neuronal function and survival. Here, APOE is linked to Alzheimer disease.